Ascendis Pharma A/S (ASND): Volume dana dhuwit perusahaan

Logo korporat perusahaan Ascendis Pharma Inc. (ASND)

Ascendis Pharma A/S (ASND) is capturing the endocrine niche, displacing legacy therapies through innovative prodrugs. The cash balance history confirms financial stability, with the current mark equal to 1.09. High scalability of patented products ensures low-cost growth, while an academic approach to science and a stock option system retain leading chemists on staff.

Aset likuid perusahaan: Ascendis Pharma AS (ASND) kanggo 04.07.2022 - 21.11.2026

Ringkesan rincian data analitis Ascendis Pharma AS (ASND)

- nilai saham lan prakiraan konsensus rega:
Ringkesan analitik perusahaan:Ascendis Pharma
Produk merek Ascendis Pharma

Ascendis Pharma A/S (ASND) is investing in large-scale clinical trials in collaboration with global endocrinology centers. The volume of available cash serves as an indicator of the business's financial flexibility when adapting to market changes. Analyzing the size of the cash reserve allows for a comparison of liquidity accumulation rates against industry standards and an assessment of solvency. A stable cash balance confirms the company's resilience, although excessive passive capital in an inflationary environment reduces the real value of assets.

Karo sapa Ascendis Pharma A/S saingan

Dana dhuwit perusahaan madrigalpharma.com (MDGL)|Dhuwit awis perusahaan Corcept Therapeutics CORT|Dana dhuwit perusahaan Rhythm Pharmaceuticals, Inc. RYTM|Volume dana dhuwit perusahaan Akero Therapeutics, Inc. AKRO|metsera.com - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan MoonLake Corp|CRNX: Volume dana dhuwit perusahaan|Dhuwit awis perusahaan NewAmsterdam Pharma|SLNO (Soleno Therapeutics Corp) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Amicus Pharma (FOLD)|Dhuwit awis perusahaan ETNB (89bio Corp)|Aset likuid perusahaan Agios Pharmaceuticals|Structure Pharma - Dhuwit awis perusahaan|MDXG: Dhuwit awis lan setara dhuwit awis perusahaan|RZLT: Dhuwit awis perusahaan|LXRX (Lexicon Pharma) - Dhuwit awis lan setara dhuwit awis perusahaan|MBX: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Altimmune, Inc. (ALT)|Dhuwit awis perusahaan AARD|Dana dhuwit perusahaan SGMT|Volume dana dhuwit perusahaan BIOA|Aset likuid perusahaan Biomea Fusion|Dana dhuwit perusahaan Quince Therapeutics QNCX|Volume dana dhuwit perusahaan Fractyl Health, Inc GUTS|VTVT: Dhuwit awis perusahaan|Cadangan dhuwit perusahaan Agape ATP|PLUR (Pluri) - Dhuwit awis perusahaan|SYBX - Aset likuid perusahaan|Dana dhuwit perusahaan Lipocine Corp|Volume dana dhuwit perusahaan matinasbiopharma.com|Dana dhuwit perusahaan Spruce Biosciences, Inc. (SPRB)|Gunggung dana dhuwit perusahaan GLTO|Carmell Corporation - Dhuwit awis perusahaan|LUMO - Dhuwit awis perusahaan|ONVO - Dana dhuwit perusahaan|Sisa dhuwit perusahaan RDUS (Radius Health)